investigated the synergistic effects of MSTN inhibitors and GLP-1 agonists by administering apitegromab in combination with semaglutide, a GLP-1 agonist, and tirzepatide, a dual agonist of GLP-1 and glucose-dependent insulinotropic polypeptide, in patients with obesity (NCT06445075)
This insight helps your provider personalize your tirzepatide strategy and meal structure based on your biology rather than generic fasting advice
Laughter MR, Maymone MBC, Mashayekhi S, et al
Regulation of Na+/H+ Exchanger NHE3 by Glucagon-Like Peptide 1 Receptor Agonist Exendin-4 in Renal Proximal Tubule Cells
Its key to know what these drugs are and why theyre used
Ozempic is not suitable for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2